Patents by Inventor David Casavant
David Casavant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10864378Abstract: Regulating cardiac activity may include pacing the patient's heart at a starting pacing rate and instigating an intrinsic heart beat search algorithm that includes pacing at a reduced rate for a period of time and capturing electrical signals representative of cardiac electrical activity while pacing at the reduced rate in order to determine a presence or absence of intrinsic heart beats. If intrinsic heart beats are not detected, the heart may be paced at a further reduced rate for a period of time. If intrinsic beats are detected, the heart may be paced again at the starting pacing rate. This may continue until intrinsic heart beats are detected or until a lower search rate limit is reached. Diagnostic data may be collected at each stage and transmitted to a display device for analysis by a physician or the like.Type: GrantFiled: March 8, 2018Date of Patent: December 15, 2020Assignee: CARDIAC PACEMAKERS, INC.Inventors: David A. Casavant, Jeffrey E. Stahmann, Carolina Villarreal, James O. Gilkerson, Deepa Mahajan, Paul Richard Holleran
-
Publication number: 20180256908Abstract: Regulating cardiac activity may include pacing the patient's heart at a starting pacing rate and instigating an intrinsic heart beat search algorithm that includes pacing at a reduced rate for a period of time and capturing electrical signals representative of cardiac electrical activity while pacing at the reduced rate in order to determine a presence or absence of intrinsic heart beats. If intrinsic heart beats are not detected, the heart may be paced at a further reduced rate for a period of time. If intrinsic beats are detected, the heart may be paced again at the starting pacing rate. This may continue until intrinsic heart beats are detected or until a lower search rate limit is reached. Diagnostic data may be collected at each stage and transmitted to a display device for analysis by a physician or the like.Type: ApplicationFiled: March 8, 2018Publication date: September 13, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: David A. Casavant, Jeffrey E. Stahmann, Carolina Villarreal, James O. Gilkerson, Deepa Mahajan, Paul Richard Holleran
-
Patent number: 9375579Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).Type: GrantFiled: June 7, 2011Date of Patent: June 28, 2016Assignee: Medtronic, Inc.Inventors: David A. Casavant, Paul Belk, Thomas J. Mullen, John C. Stroebel
-
Patent number: 9035844Abstract: The invention of the disclosure is an extension cable to connect via telemetry, an external medical device in a non-sterile zone with a medical device that is within a sterile zone. The telemetry extension cable includes a cable having a length and comprising a conductor, a first RF antenna attached at one end of the cable and a second RF antenna attached at a second end of the cable, at least one of the first or second antennas configured to transmit and receive RF signals to and from an implantable medical device.Type: GrantFiled: May 17, 2013Date of Patent: May 19, 2015Assignee: Medtronic, Inc.Inventors: Kathleen R. Malewicki, David A. Casavant, Edward D. Goff, Gary H. Kemmetmueller, David J. Peichel
-
Publication number: 20140340272Abstract: The invention of the disclosure is an extension cable to connect via telemetry, an external medical device in a non-sterile zone with a medical device that is within a sterile zone. The telemetry extension cable includes a cable having a length and comprising a conductor, a first RF antenna attached at one end of the cable and a second RF antenna attached at a second end of the cable, at least one of the first or second antennas configured to transmit and receive RF signals to and from an implantable medical device.Type: ApplicationFiled: May 17, 2013Publication date: November 20, 2014Applicant: Medtronic, Inc.Inventors: Kathleen R. Malewicki, David A. Casavant, Edward D. Goff, Gary H. Kemmetmueller, David J. Peichel
-
Publication number: 20140121716Abstract: An implantable medical device capable of delivering high voltage therapy includes a therapy delivery module comprising a high voltage therapy delivery circuit, a high voltage short circuit protection circuit configured to terminate delivery of a high voltage pulse by the therapy delivery module in response to a short circuit condition, and a sensing module for detecting a need for a high voltage therapy. The device further includes a therapy control unit configured to control the therapy delivery module to deliver a shock pulse in response to detecting the need for the high voltage therapy. The control unit detects a termination of the high voltage pulse by the protection circuit; a truncated shock charge remaining on the high voltage therapy delivery circuit upon terminating the high voltage pulse. The control unit controls the therapy delivery module to deliver a next shock pulse at the remaining truncated shock charge.Type: ApplicationFiled: October 31, 2012Publication date: May 1, 2014Applicant: Medtronic, Inc.Inventors: David A. Casavant, Mark E. Gibbs, Bruce D. Gunderson, Robert A. Betzold
-
Publication number: 20110301656Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).Type: ApplicationFiled: June 7, 2011Publication date: December 8, 2011Applicant: Medtronic, Inc.Inventors: David A. Casavant, Paul Belk, Thomas J. Mullen, John C. Stroebel
-
Patent number: 8060202Abstract: Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.Type: GrantFiled: October 6, 2009Date of Patent: November 15, 2011Assignee: Medtronic, Inc.Inventors: Robert A. Betzold, David A. Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel, Steven R. Hornberger, Todd J. Sheldon, Douglas A. Peterson
-
Patent number: 7957800Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).Type: GrantFiled: October 17, 2006Date of Patent: June 7, 2011Assignee: Medtronic, Inc.Inventors: David A. Casavant, Paul Belk, Thomas J. Mullen, John C. Stroebel
-
Patent number: 7953488Abstract: Multiple sensing configurations may be qualified based on one induced tachyarrhythmia, e.g., ventricular fibrillation, or other qualification event during an implantation procedure. Each sensing configuration comprises a different combination of two or more electrodes used for sensing electrical signals of the heart of the patient. In some examples, an implantable medical device or other device generates qualification information for each sensing configuration, which may indicate whether the sensing configuration is qualified for subsequent cardiac event detection based on an accuracy of the cardiac event detection for the sensing configuration during the qualification event. One of the qualified configurations may initially be selected as a primary sensing configuration for subsequent cardiac event detection. Switching to an alternate sensing configuration, e.g.Type: GrantFiled: July 31, 2008Date of Patent: May 31, 2011Assignee: Medtronic, Inc.Inventors: David Casavant, Catherine R. Condie, Jon W. Spence, Nathan Munsterman
-
Patent number: 7925345Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.Type: GrantFiled: October 31, 2006Date of Patent: April 12, 2011Assignee: Medtronic, Inc.Inventors: David Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
-
Patent number: 7904157Abstract: Rate responsive pacing is limited in an atrial based pacing mode by the AV interval in order to avoid or minimize ventricular encroachment of atrial pacing. The AV or VA interval is used to permit rate responsiveness; modulate rate responsiveness or to determine a dynamic upper sensor rate.Type: GrantFiled: June 18, 2007Date of Patent: March 8, 2011Assignee: Medtronic, Inc.Inventors: David A. Casavant, Paul A. Belk
-
Patent number: 7881793Abstract: A pacing protocol is provided that reduces or minimizes ventricular pacing in favor of intrinsic conduction. When operating in a mode that provides ventricular pacing, a series of conduction checks are performed to determine if intrinsic conduction has returned. These conduction checks occur according to a predetermined pattern that general includes longer intervals between subsequent attempts. A maximum interval is provided such that conduction checks are not repeated sequentially at the same time of day when at this maximum interval.Type: GrantFiled: March 31, 2005Date of Patent: February 1, 2011Assignee: Medtronic, Inc.Inventors: Robert A. Betzold, David A. Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
-
Patent number: 7738955Abstract: A pacing protocol is provided that reduces or minimizes ventricular pacing in favor of intrinsic conduction. When operating in a mode that provides ventricular pacing, a series of conduction checks are performed to determine if intrinsic conduction has returned. These conduction checks occur according to a predetermined pattern that generally includes longer intervals between subsequent attempts. The AV interval provided for dual chamber based pacing is modulated and generally moves from a larger value to a nominal value as the interval between unsuccessful conduction checks increases.Type: GrantFiled: April 27, 2005Date of Patent: June 15, 2010Assignee: Medtronic, Inc.Inventors: Michael O. Sweeney, David A. Casavant, Robert A. Betzold, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
-
Publication number: 20100087882Abstract: Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.Type: ApplicationFiled: October 6, 2009Publication date: April 8, 2010Applicant: Medtronic, Inc.Inventors: Robert A. Betzold, David A. Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel, Steven R. Hornberger, Todd J. Sheldon, Douglas A. Peterson
-
Publication number: 20100030289Abstract: Multiple sensing configurations may be qualified based on one induced tachyarrhythmia, e.g., ventricular fibrillation, or other qualification event during an implantation procedure. Each sensing configuration comprises a different combination of two or more electrodes used for sensing electrical signals of the heart of the patient. In some examples, an implantable medical device or other device generates qualification information for each sensing configuration, which may indicate whether the sensing configuration is qualified for subsequent cardiac event detection based on an accuracy of the cardiac event detection for the sensing configuration during the qualification event. One of the qualified configurations may initially be selected as a primary sensing configuration for subsequent cardiac event detection. Switching to an alternate sensing configuration, e.g.Type: ApplicationFiled: July 31, 2008Publication date: February 4, 2010Applicant: Medtronic, Inc.Inventors: David Casavant, Catherine R. Condie, Jon W. Spence, Nathan Munsterman
-
Patent number: 7599740Abstract: Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.Type: GrantFiled: May 15, 2007Date of Patent: October 6, 2009Assignee: Medtronic, Inc.Inventors: Robert A. Betzold, David A. Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel, Steven R. Hornberger, Todd J. Sheldon, Douglas A. Peterson
-
Patent number: 7587242Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).Type: GrantFiled: June 29, 2006Date of Patent: September 8, 2009Assignee: Medtronic, Inc.Inventors: David A. Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
-
Publication number: 20070299478Abstract: Rate responsive pacing is limited in an atrial based pacing mode by the AV interval in order to avoid or minimize ventricular encroachment of atrial pacing. The AV or VA interval is used to permit rate responsiveness; modulate rate responsiveness or to determine a dynamic upper sensor rate.Type: ApplicationFiled: June 18, 2007Publication date: December 27, 2007Inventors: David Casavant, Paul Belk
-
Patent number: 7277757Abstract: The invention is directed to an implantable medical device that stimulates a nerve associated with respiration. The nerve may, for example be a phrenic nerve, and the stimulation may cause a diaphragm of the patient to contract. The implantable medical device receives a signal that indicates a need for increased cardiac output and stimulates the nerve in response to the signal. The implantable medical device may receive such a signal by, for example, detecting a ventricular tachyarrhythmia, sensing a pressure that indicates a need for increased cardiac output, or receiving a signal from a patient via a patient activator. Stimulation of the nerve may increase cardiac output of a beating or defibrillating heart.Type: GrantFiled: October 31, 2002Date of Patent: October 2, 2007Assignee: Medtronic, Inc.Inventors: David A. Casavant, William J. Havel